Comment from William Fitzsimmons

Summary: Dr. William E. Fitzsimmons from the University of Illinois at Chicago supports the drug repurposing initiative, specifically advocating for the inclusion of solid organ transplant immunosuppression as a priority area. He identifies several specific drugs for repurposing (such as Basiliximab and Mycophenolate mofetil) and suggests waiving user fees to overcome commercial barriers.